BTG-002814 / Boston Scientific, UCL Cancer Institute  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BTG-002814 / Boston Scientific
2017-002517-64: A trial of tiny beads linked to an anti-cancer drug (vandetanib) injected into liver tumours

Not yet recruiting
1/2
56
Europe
Vandetanib Eluting Radiopaque Bead, BTG-002814, Implant
Biocompatibles UK Ltd, Biocompatibles UK Ltd
Hepatocellular Carcinoma (HCC), Liver Cancer, Diseases [C] - Cancer [C04]
 
 

Download Options